Alembic Pharma earmarks capex of Rs 720 crore for FY19

04 Jun 2018 Evaluate

In order to complete existing projects, Alembic Pharmaceuticals has earmarked a capital expenditure of Rs 720 crore for FY19. The company had spent about Rs 600 crore of capex in the last fiscal year.

The pharma firm has filed 12 ANDAs (abbreviated new drug applications) during the March quarter, taking the total filings in FY18 to 26.

The company has six formulation and three API manufacturing facilities. It manufactures general oral solids in Panelav near Vadodara, Gujarat, and is in the process of putting up oncology oral solids and oncology injectable facilities at the same location.

Alembic Pharma Share Price

761.15 -6.00 (-0.78%)
20-Feb-2026 14:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1725.60
Dr. Reddys Lab 1285.00
Cipla 1340.20
Zydus Lifesciences 902.85
Lupin 2218.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×